Endurant Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,400
Closed -$1.83M 81
2022
Q1
$1.83M Buy
15,400
+9,331
+154% +$1.11M 0.48% 39
2021
Q4
$836K Buy
+6,069
New +$836K 0.2% 59
2019
Q2
Sell
-7,479
Closed -$385K 89
2019
Q1
$385K Buy
+7,479
New +$385K 0.15% 62
2018
Q1
Sell
-10,300
Closed -$278K 92
2017
Q4
$278K Buy
+10,300
New +$278K 0.09% 74